Annual Meeting of the Endocrine Society (ENDO)

Presentation Title: Ersodetug (RZ358) in Congenital Hyperinsulinism: Top-Line Results from a Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (sunRIZE)
Format: Oral presentation
Presenter: Huseyin Demirbilek, M.D.
Poster Number: SAT-10-06
Session Date and Time: Saturday, June 13, 2026, from 2:30 - 2:45 p.m. CDT
Session Title: Pediatric and Adolescent Endocrinology: Diabetes and Insulin

Presentation Title: A Case Series on the Compassionate Use of Ersodetug, an Insulin Receptor Modulating Antibody, in Patients with Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors
Format: Poster presentation
Presenter: Gopal Saha, M.B.B.S.
Poster Number: SAT-087
Session Date and Time: Saturday, June 13, 2026, from 12:15 - 1:45 p.m. CDT
Session Title: Neuroendocrinology and Pituitary: Neuroendocrine Tumors I

Presentation Title: Association of Early-Life Hypoglycemia with Later Neurological Outcomes in Congenital Hyperinsulinism: A US Claims-Based Study 
Format: Poster presentation
Presenter: Cody Akana
Poster Number: SAT-221
Session Date and Time: Saturday, June 13, 2026, from 12:15 - 1:45 p.m. CDT
Session Title: Pediatric and Adolescent Endocrinology: Pediatric Diabetes, Metabolic and Cardiovascular Disorders I

Presentation Title: Outcomes in Congenital Hyperinsulinism: A Systematic Review
Format: Poster presentation
Presenter: Davelyn Eaves Hood, M.D., M.B.A.
Poster Number: MON-215
Session Date and Time: Monday, June 15, 2026, from 12:00 - 1:30 p.m. CDT
Session Title: Pediatric and Adolescent Endocrinology: Pediatric Diabetes, Metabolic and Cardiovascular Disorders III

For more information on the conference presentation schedule, please visit the ENDO 2026 website.